Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

metformin; vildagliptin - filmsko obložena tableta - metformin 780 mg / 1 tableta  vildagliptin50 mg / 1 tableta; vildagliptin 50 mg / 1 tableta - metformin in vildagliptin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

metformin; vildagliptin - filmsko obložena tableta - metformin 780 mg / 1 tableta  vildagliptin50 mg / 1 tableta; vildagliptin 50 mg / 1 tableta - metformin in vildagliptin

Evropska unija - slovenščina - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformin hidroklorid - diabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Evropska unija - slovenščina - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformin hidroklorid - diabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 in 5. 1 za razpoložljive podatke o različnih kombinacijah).

Evropska unija - slovenščina - EMA (European Medicines Agency)

novartis europharm limited  - vildagliptin, metformin hidroklorid - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sandoz d.d. - metformin; vidagliptin - filmsko obložena tableta - metformin 660 mg / 1 tableta  vidagliptin50 mg / 1 tableta; vidagliptin 50 mg / 1 tableta - metformin in vildagliptin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sandoz d.d. - metformin, vidagliptin - filmsko obložena tableta - metformin 780 mg / 1 tableta; vidagliptin 50 mg / 1 tableta - metformin in vildagliptin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sandoz d.d. - metformin; vidagliptin - filmsko obložena tableta - metformin 780 mg / 1 tableta  vidagliptin50 mg / 1 tableta; vidagliptin 50 mg / 1 tableta - metformin in vildagliptin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sandoz d.d. - metformin; vidagliptin - filmsko obložena tableta - metformin 660 mg / 1 tableta  vidagliptin50 mg / 1 tableta; vidagliptin 50 mg / 1 tableta - metformin in vildagliptin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

metformin; vildagliptin - filmsko obložena tableta - metformin 662,88 mg / 1 tableta  vildagliptin50 mg / 1 tableta; vildagliptin 50 mg / 1 tableta - metformin in vildagliptin